A compound represented by the formula (I): wherein each symbol is as defined in the specification, and a salt thereof have a GPR40 receptor activation action and is useful as an insulin secretagogue or a prophylactic or therapeutic drug for diabetes and the like.
[EN] NOVEL FUSED CYCLIC COMPOUND AND USE THEREOF<br/>[FR] NOUVEAU COMPOSÉ CYCLIQUE FONDU ET SON UTILISATION
申请人:TAKEDA PHARMACEUTICAL
公开号:WO2010143733A1
公开(公告)日:2010-12-16
A compound represented by the formula (I): wherein each symbol is as defined in the specification, and a salt thereof have a GPR40 receptor activation action and is useful as an insulin secretagogue or a prophylactic or therapeutic drug for diabetes and the like.